These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9051205)

  • 1. The replacement of arginine by cysteine at residue 151 in apolipoprotein A-I produces a phenotype similar to that of apolipoprotein A-IMilano.
    Bruckert E; von Eckardstein A; Funke H; Beucler I; Wiebusch H; Turpin G; Assmann G
    Atherosclerosis; 1997 Jan; 128(1):121-8. PubMed ID: 9051205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compound heterozygosity for a structural apolipoprotein A-I variant, apo A-I(L141R)Pisa, and an apolipoprotein A-I null allele in patients with absence of HDL cholesterol, corneal opacifications, and coronary heart disease.
    Miccoli R; Bertolotto A; Navalesi R; Odoguardi L; Boni A; Wessling J; Funke H; Wiebusch H; Eckardstein A; Assmann G
    Circulation; 1996 Oct; 94(7):1622-8. PubMed ID: 8840853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel nonsense apolipoprotein A-I mutation (apoA-I(E136X)) causes low HDL cholesterol in French Canadians.
    Dastani Z; Dangoisse C; Boucher B; Desbiens K; Krimbou L; Dufour R; Hegele RA; Pajukanta P; Engert JC; Genest J; Marcil M
    Atherosclerosis; 2006 Mar; 185(1):127-36. PubMed ID: 16023124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ApoA-IHelsinki (Lys107-->0) associated with reduced HDL cholesterol and LpA-I:A-II deficiency.
    Tilly-Kiesi M; Zhang Q; Ehnholm S; Kahri J; Lahdenperä S; Ehnholm C; Taskinen MR
    Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1294-306. PubMed ID: 7670941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High density lipoprotein particle size restriction in apolipoprotein A-I(Milano) transgenic mice.
    Bielicki JK; Forte TM; McCall MR; Stoltzfus LJ; Chiesa G; Sirtori CR; Franceschini G; Rubin EM
    J Lipid Res; 1997 Nov; 38(11):2314-21. PubMed ID: 9392429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel LCAT mutation (Phe382-->Val) in a kindred with familial LCAT deficiency and defective apolipoprotein B-100.
    Nanjee MN; Stocks J; Cooke CJ; Molhuizen HO; Marcovina S; Crook D; Kastelein JP; Miller NE
    Atherosclerosis; 2003 Sep; 170(1):105-13. PubMed ID: 12957688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that apolipoprotein A-IMilano has reduced capacity, compared with wild-type apolipoprotein A-I, to recruit membrane cholesterol.
    Bielicki JK; McCall MR; Stoltzfus LJ; Ravandi A; Kuksis A; Rubin EM; Forte TM
    Arterioscler Thromb Vasc Biol; 1997 Sep; 17(9):1637-43. PubMed ID: 9327756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe familial HDL deficiency in French-Canadian kindreds. Clinical, biochemical, and molecular characterization.
    Marcil M; Boucher B; Krimbou L; Solymoss BC; Davignon J; Frohlich J; Genest J
    Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1015-24. PubMed ID: 7627690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of the phenotypic expression of the A-IMilano apoprotein with plasma lipid and lipoprotein patterns.
    Franceschini G; Sirtori CR; Bosisio E; Gualandri V; Orsini GB; Mogavero AM; Capurso A
    Atherosclerosis; 1985 Dec; 58(1-3):159-74. PubMed ID: 3937534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential gene therapy for lecithin-cholesterol acyltransferase (LCAT)-deficient and hypoalphalipoproteinemic patients with adenovirus-mediated transfer of human LCAT gene.
    Séguret-Macé S; Latta-Mahieu M; Castro G; Luc G; Fruchart JC; Rubin E; Denèfle P; Duverger N
    Circulation; 1996 Nov; 94(9):2177-84. PubMed ID: 8901669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial lecithin:cholesterol acyltransferase deficiency: molecular analysis of a compound heterozygote: LCAT (Arg147 --> Trp) and LCAT (Tyr171 --> Stop).
    Guerin M; Dachet C; Goulinet S; Chevet D; Dolphin PJ; Chapman MJ; Rouis M
    Atherosclerosis; 1997 May; 131(1):85-95. PubMed ID: 9180249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A unique genetic and biochemical presentation of fish-eye disease.
    Kuivenhoven JA; van Voorst tot Voorst EJ; Wiebusch H; Marcovina SM; Funke H; Assmann G; Pritchard PH; Kastelein JJ
    J Clin Invest; 1995 Dec; 96(6):2783-91. PubMed ID: 8675648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein A-I(Zavalla) (Leu159-->Pro): HDL cholesterol deficiency in a kindred associated with premature coronary artery disease.
    Miller M; Aiello D; Pritchard H; Friel G; Zeller K
    Arterioscler Thromb Vasc Biol; 1998 Aug; 18(8):1242-7. PubMed ID: 9714130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subpopulations of high density lipoproteins in homozygous and heterozygous Tangier disease.
    Asztalos BF; Brousseau ME; McNamara JR; Horvath KV; Roheim PS; Schaefer EJ
    Atherosclerosis; 2001 May; 156(1):217-25. PubMed ID: 11369017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo metabolism of a mutant form of apolipoprotein A-I, apo A-IMilano, associated with familial hypoalphalipoproteinemia.
    Roma P; Gregg RE; Meng MS; Ronan R; Zech LA; Franceschini G; Sirtori CR; Brewer HB
    J Clin Invest; 1993 Apr; 91(4):1445-52. PubMed ID: 8473493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lecithin:cholesterol acyl transferase G30S: association with atherosclerosis, hypoalphalipoproteinemia and reduced in vivo enzyme activity.
    Rosset J; Wang J; Wolfe BM; Dolphin PJ; Hegele RA
    Clin Biochem; 2001 Jul; 34(5):381-6. PubMed ID: 11522275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High density lipoproteins, reverse transport of cholesterol, and coronary artery disease. Insights from mutations.
    Assmann G; von Eckardstein A; Funke H
    Circulation; 1993 Apr; 87(4 Suppl):III28-34. PubMed ID: 8462178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High density lipoprotein deficiency with xanthomas. A defect in reverse cholesterol transport caused by a point mutation in the apolipoprotein A-I gene.
    Lackner KJ; Dieplinger H; Nowicka G; Schmitz G
    J Clin Invest; 1993 Nov; 92(5):2262-73. PubMed ID: 7693760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterozygosity for apolipoprotein A-I(R160L)Oslo is associated with low levels of high density lipoprotein cholesterol and HDL-subclass LpA-I/A-II but normal levels of HDL-subclass LpA-I.
    Leren TP; Bakken KS; Daum U; Ose L; Berg K; Assmann G; von Eckardstein A
    J Lipid Res; 1997 Jan; 38(1):121-31. PubMed ID: 9034206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced fractional catabolic rate of apo A-I and apo A-II in heterozygous subjects for apo A-I(Zaragoza) (L144R).
    Recalde D; Velez-Carrasco W; Civeira F; Cenarro A; Gomez-Coronado D; Ordovas JM; Pocovi M
    Atherosclerosis; 2001 Feb; 154(3):613-23. PubMed ID: 11257262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.